Larvol Delta - aTyr-Pharma-Presents-Preclinical-Research-Demonstrating-Treatment-with-ATYR2810-Inhibits-Tumor-Growth-and-Therapy-Resistance-in-Highly-Aggressive-Cancers-at-the-2023-AACR-Annual-Meeting

ATYR2810 - aTyr Pharma

https://www.globenewswire.com/news-release/2023/04/17/2647875/0/en/aTyr-Pharma-Presents-Preclinical-Research-Demonstrating-Treatment-with-ATYR2810-Inhibits-Tumor-Growth-and-Therapy-Resistance-in-Highly-Aggressive-Cancers-at-the-2023-AACR-Annual-Me.html

Apr 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next